Original Research
21 December 2010

Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults: A Cohort Study

Publication: Annals of Internal Medicine
Volume 153, Number 12

Abstract

Background:

Palmitoleic acid (cis-16:1n-7), which is produced by endogenous fat synthesis, has been linked to both beneficial and deleterious metabolic effects, potentially confounded by diverse determinants and tissue sources of endogenous production. Trans-palmitoleate (trans-16:1n-7) represents a distinctly exogenous source of 16:1n-7, unconfounded by endogenous synthesis or its determinants, that may be uniquely informative.

Objective:

To investigate whether circulating trans-palmitoleate is independently related to lower metabolic risk and incident type 2 diabetes.

Design:

Prospective cohort study from 1992 to 2006.

Setting:

Four U.S. communities.

Patients:

3736 adults in the Cardiovascular Health Study.

Measurements:

Anthropometric characteristics and levels of plasma phospholipid fatty acids, blood lipids, inflammatory markers, and glucose–insulin measured at baseline in 1992 and dietary habits measured 3 years earlier. Multivariate-adjusted models were used to investigate how demographic, clinical, and lifestyle factors independently related to plasma phospholipid trans-palmitoleate; how trans-palmitoleate related to major metabolic risk factors; and how trans-palmitoleate related to new-onset diabetes (304 incident cases). Findings were validated for metabolic risk factors in an independent cohort of 327 women.

Results:

In multivariate analyses, whole-fat dairy consumption was most strongly associated with higher trans-palmitoleate levels. Higher trans-palmitoleate levels were associated with slightly lower adiposity and, independently, with higher high-density lipoprotein cholesterol levels (1.9% across quintiles; P = 0.040), lower triglyceride levels (−19.0%; P < 0.001), a lower total cholesterol–HDL cholesterol ratio (−4.7%; P < 0.001), lower C-reactive protein levels (−13.8%; P = 0.05), and lower insulin resistance (−16.7%, P < 0.001). Trans-palmitoleate was also associated with a substantially lower incidence of diabetes, with multivariate hazard ratios of 0.41 (95% CI, 0.27 to 0.64) and 0.38 (CI, 0.24 to 0.62) in quintiles 4 and 5 versus quintile 1 (P for trend < 0.001). Findings were independent of estimated dairy consumption or other fatty acid dairy biomarkers. Protective associations with metabolic risk factors were confirmed in the validation cohort.

Limitation:

Results could be affected by measurement error or residual confounding.

Conclusion:

Circulating trans-palmitoleate is associated with lower insulin resistance, presence of atherogenic dyslipidemia, and incident diabetes. Our findings may explain previously observed metabolic benefits of dairy consumption and support the need for detailed further experimental and clinical investigation.

Primary Funding Source:

National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Cao HGerhold KMayers JRWiest MMWatkins SMHotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008;134:933-44. [PMID: 18805087]
2.
Dimopoulos NWatson MSakamoto KHundal HS. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J. 2006;399:473-81. [PMID: 16822230]
3.
Sauma LStenkula KGKjølhede PStrålfors PSöderström MNystrom FH. PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids. Nutrition. 2006;22:60-8. [PMID: 16226011]
4.
Maedler KOberholzer JBucher PSpinas GADonath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003;52:726-33. [PMID: 12606514]
5.
Erbay EBabaev VRMayers JRMakowski LCharles KNSnitow MEet al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med. 2009;15:1383-91. [PMID: 19966778]
6.
Cambien FWarnet JMVernier VDucimetière PJacqueson AFlament Cet al. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol. 1988;127:75-86. [PMID: 3276162]
7.
Rössner SWalldius GBjörvell H. Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes. 1989;13:603-12. [PMID: 2583914]
8.
Okada TFuruhashi NKuromori YMiyashita MIwata FHarada K. Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr. 2005;82:747-50. [PMID: 16210702]
9.
Sarabi MVessby BMillgård JLind L. Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. Atherosclerosis. 2001;156:349-55. [PMID: 11395031]
10.
Petersson HLind LHulthe JElmgren ACederholm TRisérus U. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis. 2009;203:298-303. [PMID: 18687433]
11.
Simon JAFong JBernert JT Jr. Serum fatty acids and blood pressure. Hypertension. 1996;27:303-7. [PMID: 8567056]
12.
Lindgärde FVessby BAhrén B. Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women. Am J Clin Nutr. 2006;84:1009-13. [PMID: 17093151]
13.
Vessby BTengblad SLithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia. 1994;37:1044-50. [PMID: 7851683]
14.
Kusunoki MTsutsumi KNakayama MKurokawa TNakamura TOgawa Het al. Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus. J Med Invest. 2007;54:243-7. [PMID: 17878672]
15.
Salomaa VAhola ITuomilehto JAro APietinen PKorhonen HJet al. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism. 1990;39:1285-91. [PMID: 2246969]
16.
Vessby BAro ASkarfors EBerglund LSalminen ILithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes. 1994;43:1353-7. [PMID: 7926311]
17.
Iggman DArnlöv JVessby BCederholm TSjögren PRisérus U. Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia. 2010;53:850-7. [PMID: 20127308]
18.
Gertow KRosell MSjögren PEriksson PVessby Bde Faire Uet al. Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance. Eur J Clin Nutr. 2006;60:1406-13. [PMID: 16788709]
19.
Stefan NKantartzis KCelebi NStaiger HMachann JSchick Fet al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care. 2010;33:405-7. [PMID: 19889804]
20.
Mozaffarian DCao HKing IBLemaitre RNSong XSiscovick DSet al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr. 2010. [PMID: 20943795]
21.
Maguire LSO'Sullivan SMGalvin KO'Connor TPO'Brien NM. Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr. 2004;55:171-8. [PMID: 15223592]
22.
Mozaffarian DKatan MBAscherio AStampfer MJWillett WCTrans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601-13. [PMID: 16611951]
23.
Micha RKing IBLemaitre RNRimm EBSacks FSong Xet al. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr. 2010;91:883-93. [PMID: 20219966]
24.
Elwood PCGivens DIBeswick ADFehily AMPickering JEGallacher J. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr. 2008;27:723S-34S. [PMID: 19155432]
25.
Tremblay AGilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr. 2009;28 Suppl 1 91S-102S. [PMID: 19571167]
26.
Fried LPBorhani NOEnright PFurberg CDGardin JMKronmal RAet al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-76. [PMID: 1669507]
27.
Lemaitre RNKing IBMozaffarian DSotoodehnia NRea TDKuller LHet al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation. 2006;114:209-15. [PMID: 16818809]
28.
King IBLemaitre RNKestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr. 2006;83:227-36. [PMID: 16469979]
29.
Lemaitre RNKing IBMozaffarian DKuller LHTracy RPSiscovick DS. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2003;77:319-25. [PMID: 12540389]
30.
Folch JLees MSloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509. [PMID: 13428781]
31.
Lepage GRoy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114-20. [PMID: 3958609]
32.
Rosner BHennekens CHKass EHMiall WE. Age-specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol. 1977;106:306-13. [PMID: 910798]
33.
Kumanyika SKTell GSShemanski LMartel JChinchilli VM. Dietary assessment using a picture-sort approach. Am J Clin Nutr. 1997;65:1123S-1129S. [PMID: 9094908]
34.
Sun QMa JCampos HRexrode KMAlbert CMMozaffarian Det al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr. 2008;88:216-23. [PMID: 18614744]
35.
Royston P. Multiple imputation of missing values. Stata J. 2004;4:227-41.
36.
Wolk AVessby BLjung HBarrefors P. Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr. 1998;68:291-5. [PMID: 9701185]
37.
Wolk AFuruheim MVessby B. Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr. 2001;131:828-33. [PMID: 11238766]
38.
Brevik AVeierød MBDrevon CAAndersen LF. Evaluation of the odd fatty acids 15:0 and 17:0 in serum and adipose tissue as markers of intake of milk and dairy fat. Eur J Clin Nutr. 2005;59:1417-22. [PMID: 16118654]
39.
Pradhan ADManson JERifai NBuring JERidker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34. [PMID: 11466099]
40.
Devaraj SSingh UJialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009;20:182-9. [PMID: 19369869]
41.
Barazzoni RKiwanuka EZanetti MCristini MVettore MTessari P. Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes. Diabetes. 2003;52:1851-6. [PMID: 12829656]
42.
Sommerfeld MTrans unsaturated fatty acids in natural products and processed foods. Prog Lipid Res. 1983;22:221-33. [PMID: 6356151]
43.
Postic CGirard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest. 2008;118:829-38. [PMID: 18317565]
44.
Musso GGambino RCassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48:1-26. [PMID: 18824034]
45.
Lim JSMietus-Snyder MValente ASchwarz JMLustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7:251-64. [PMID: 20368739]
46.
Hudgins LCHellerstein MSeidman CNeese RDiakun JHirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest. 1996;97:2081-91. [PMID: 8621798]
47.
Marques-Lopes IAnsorena DAstiasaran IForga LMartínez JA. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am J Clin Nutr. 2001;73:253-61. [PMID: 11157321]
48.
Schwarz JMLinfoot PDare DAghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77:43-50. [PMID: 12499321]
49.
Hudgins LCBaday AHellerstein MKParker TSLevine DMSeidman CEet al. The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjects. J Nutr Biochem. 2008;19:237-45. [PMID: 17618104]
50.
Chong MFHodson LBickerton ASRoberts RNeville MKarpe Fet al. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am J Clin Nutr. 2008;87:817-23. [PMID: 18400702]
51.
Baumgard LHMatitashvili ECorl BADwyer DABauman DEtrans-10, cis-12 conjugated linoleic acid decreases lipogenic rates and expression of genes involved in milk lipid synthesis in dairy cows. J Dairy Sci. 2002;85:2155-63. [PMID: 12362447]
52.
Harvatine KJPerfield JW 2ndBauman DE. Expression of enzymes and key regulators of lipid synthesis is upregulated in adipose tissue during CLA-induced milk fat depression in dairy cows. J Nutr. 2009;139:849-54. [PMID: 19211829]
53.
Hodgson JMWahlqvist MLBoxall JABalazs ND. Platelet trans fatty acids in relation to angiographically assessed coronary artery disease. Atherosclerosis. 1996;120:147-54. [PMID: 8645355]
54.
Willett WMozaffarian D. Ruminant or industrial sources of trans fatty acids: public health issue or food label skirmish? [Editorial]. Am J Clin Nutr. 2008;87:515-6. [PMID: 18326587]
55.
Azadbakht LMirmiran PEsmaillzadeh AAzizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 2005;82:523-30. [PMID: 16155263]
56.
Mirmiran PEsmaillzadeh AAzizi F. Dairy consumption and body mass index: an inverse relationship. Int J Obes (Lond). 2005;29:115-21. [PMID: 15534616]
57.
Pereira MAJacobs DR JrVan Horn LSlattery MLKartashov AILudwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002;287:2081-9. [PMID: 11966382]
58.
Choi HKWillett WCStampfer MJRimm EHu FB. Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med. 2005;165:997-1003. [PMID: 15883237]
59.
Rosell MHåkansson NNWolk A. Association between dairy food consumption and weight change over 9 y in 19,352 perimenopausal women. Am J Clin Nutr. 2006;84:1481-8. [PMID: 17158433]
60.
Liu SChoi HKFord ESong YKlevak ABuring JEet al. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care. 2006;29:1579-84. [PMID: 16801582]
61.
Beydoun MAGary TLCaballero BHLawrence RSCheskin LJWang Y. Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr. 2008;87:1914-25. [PMID: 18541585]
62.
Elwood PCPickering JEFehily AM. Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health. 2007;61:695-8. [PMID: 17630368]
63.
Vergnaud ACPéneau SChat-Yung SKesse ECzernichow SGalan Pet al. Dairy consumption and 6-y changes in body weight and waist circumference in middle-aged French adults. Am J Clin Nutr. 2008;88:1248-55. [PMID: 18996859]
64.
Chardigny JMDestaillats FMalpuech-Brugère CMoulin JBauman DELock ALet al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr. 2008;87:558-66. [PMID: 18326592]
65.
Motard-Bélanger ACharest AGrenier GPaquin PChouinard YLemieux Set al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr. 2008;87:593-9. [PMID: 18326596]
66.
Risérus USmedman ABasu SVessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr. 2004;79:1146S-1148S. [PMID: 15159248]
67.
Moloney FYeow TPMullen ANolan JJRoche HM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80:887-95. [PMID: 15447895]
68.
Zemel MBThompson WMilstead AMorris KCampbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004;12:582-90. [PMID: 15090625]
69.
Harvey-Berino JGold BCLauber RStarinski A. The impact of calcium and dairy product consumption on weight loss. Obes Res. 2005;13:1720-6. [PMID: 16286519]

Comments

0 Comments
Sign In to Submit A Comment

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 153Number 1221 December 2010
Pages: 790 - 799

History

Published online: 21 December 2010
Published in issue: 21 December 2010

Keywords

Authors

Affiliations

Dariush Mozaffarian, MD, DrPH
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Haiming Cao, PhD
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Irena B. King, PhD
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Rozenn N. Lemaitre, PhD, MPH
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Xiaoling Song, PhD
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
David S. Siscovick, MD, MPH
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Gökhan S. Hotamisligil, MD, PhD
From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland; University of New Mexico, Albuquerque, New Mexico; and Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Acknowledgment: The authors thank the CHS participants. A full list of participating CHS investigators and institutions is available at www.chs-nhlbi.org.
Grant Support: By the National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (grants R01-HL085710, DK064360, and DK71507-04 and grants N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through -85086, N01-HC-15103, N01-HC-55222, and U01-HL080295 for the CHS), with additional contributions from the National Institutes of Health Office of Dietary Supplements and National Institute of Neurological Disorders and Stroke. A subset of additional fatty acid measurements was supported by a Searle Scholar Award.
Reproducible Research Statement: Study protocol and statistical code: Available from Dr. Mozaffarian (e-mail, [email protected]). Data set: Available through established Cardiovascular Health Study procedures for obtaining and analyzing data; see www.chs-nhlbi.org/CHS_DistribPolicy.htm.
Corresponding Author: Dariush Mozaffarian, MD, DrPH, Harvard School of Public Health; 665 Huntington Avenue, Building 2-319, Boston, MA 02115; e-mail, [email protected].
Current Author Addresses: Dr. Mozaffarian: Harvard School of Public Health, 665 Huntington Avenue, Building 2-319, Boston, MA 02115.
Dr. Cao: National Institutes of Health, 10 Center Drive, Building 10, 8N105A, Bethesda, MD 20892.
Dr. King: University of New Mexico, 2703 Frontier Avenue Northeast, Suite 190, Albuquerque, NM 87131.
Drs. Lemaitre and Siscovick: Cardiovascular Health Research Unit, 1730 Minor Avenue, Suite 1360, Seattle, WA 98101.
Dr. Song: Fred Hutchinson Cancer Research Center, M5 A864, 1100 Fairview Avenue North, Seattle, WA 98109.
Dr. Hotamisligil: Harvard School of Public Health, 665 Huntington Avenue, Building 1-605, Boston, MA 02115.
Author Contributions: Conception and design: D. Mozaffarian, H. Cao, I.B. King, G.S. Hotamisligil.
Analysis and interpretation of the data: D. Mozaffarian, H. Cao, I.B. King, R.N. Lemaitre, X. Song, D.S. Siscovick, G.S. Hotamisligil.
Drafting of the article: D. Mozaffarian.
Critical revision of the article for important intellectual content: D. Mozaffarian, I.B. King, R.N. Lemaitre, X. Song, D.S. Siscovick, G.S. Hotamisligil.
Final approval of the article: D. Mozaffarian, H. Cao, I.B. King, R.N. Lemaitre, X. Song, D.S. Siscovick, G.S. Hotamisligil.
Statistical expertise: D. Mozaffarian.
Obtaining of funding: D. Mozaffarian.
Administrative, technical, or logistic support: H. Cao, X. Song.
Collection and assembly of data: D. Mozaffarian, I.B. King, X. Song, D.S. Siscovick.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Dariush Mozaffarian, Haiming Cao, Irena B. King, et al. Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults: A Cohort Study. Ann Intern Med.2010;153:790-799. [Epub 21 December 2010]. doi:10.7326/0003-4819-153-12-201012210-00005

View More

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/EPUB

View PDF/EPUB

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media